Formulation

The year 2007 witnessed the approval of fifteen biopharmaceuticals in the United States and European Union.

Set limits to provide incentives for process improvements.

Resolve confusion about measurements.

US Food and Drug Administration's Division of Biologic Oncology Products has approved two new biologics license application (BLA) supplements expanding the approval of Genentech's Herceptin (trastuzumab) for the treatment of breast cancer.

Adjuvant-caused vaccine reactions are one of the most important barriers to better acceptance of routine prophylactic vaccination.

The biopharmaceutical industry has gained a lot of experience in monitoring glycosylation, but still has a lot to learn about the structure–function relationship.

The transdermal delivery of biologics-as well as of conventional drugs-is growing in popularity because the technique offers numerous advantages.

The type of reactive moiety controls the site and stability of the covalent link and also the total number of PEGylation sites on a given protein.